Leidos Delivers Strong Third Quarter and Enhances Full-Year Guidance
Revenues of $4.6 billion, up 4% year-over-year Net income of $413 million or $3.28 per diluted share Adjusted EBITDA (non-GAAP) of $644 million and Adjusted EBITDA margin (non-GAAP) of 13.9% Non-GAAP Diluted Earnings per Share of $3.62, up 19% year-over-year Cash Flows from Operations of...
Covered in this story
Analyst targets on Leidos
- JPMorgan: $115 → $142 by Oct 2027 · Neutral via Investing.com
- TD Cowen: $129 → $135 by Sep 2027 · Hold via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $LDOS yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Leidos →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.